| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |